These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 33920428)

  • 1. Endocrine-Disrupting Chemicals and Infectious Diseases: From Endocrine Disruption to Immunosuppression.
    Adegoke EO; Rahman MS; Park YJ; Kim YJ; Pang MG
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunomodulatory effects of environmental endocrine disrupting chemicals.
    Kuo CH; Yang SN; Kuo PL; Hung CH
    Kaohsiung J Med Sci; 2012 Jul; 28(7 Suppl):S37-42. PubMed ID: 22871600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocrine-Disrupting Chemicals and Disease Endpoints.
    Ahn C; Jeung EB
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocrine disrupting chemicals and disease susceptibility.
    Schug TT; Janesick A; Blumberg B; Heindel JJ
    J Steroid Biochem Mol Biol; 2011 Nov; 127(3-5):204-15. PubMed ID: 21899826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocrine disrupting chemicals and COVID-19 relationships: A computational systems biology approach.
    Wu Q; Coumoul X; Grandjean P; Barouki R; Audouze K
    Environ Int; 2021 Dec; 157():106232. PubMed ID: 33223326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perinatal exposure to endocrine disrupting chemicals and neurodevelopment: How articles of daily use influence the development of our children.
    O'Shaughnessy KL; Fischer F; Zenclussen AC
    Best Pract Res Clin Endocrinol Metab; 2021 Sep; 35(5):101568. PubMed ID: 34565681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormonally active agents in the environment: a state-of-the-art review.
    Anwer F; Chaurasia S; Khan AA
    Rev Environ Health; 2016 Dec; 31(4):415-433. PubMed ID: 27487487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Firm human evidence on harms of endocrine-disrupting chemicals was unlikely to be obtainable for methodological reasons.
    Lee DH; Jacobs DR
    J Clin Epidemiol; 2019 Mar; 107():107-115. PubMed ID: 30543909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocrine Disrupting Chemicals' Effects in Children: What We Know and What We Need to Learn?
    Predieri B; Iughetti L; Bernasconi S; Street ME
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of endocrine-disrupting chemicals on placental development.
    Yan Y; Guo F; Liu K; Ding R; Wang Y
    Front Endocrinol (Lausanne); 2023; 14():1059854. PubMed ID: 36896182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical epidemiology studies on potential effects of endocrine disrupting chemicals (EDCs) should exclude subjects with obesity as determined by BMI.
    Smith CJ; Perfetti TA; Hayes AW; Berry SC
    Regul Toxicol Pharmacol; 2020 Aug; 115():104711. PubMed ID: 32598900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A curated knowledgebase on endocrine disrupting chemicals and their biological systems-level perturbations.
    Karthikeyan BS; Ravichandran J; Mohanraj K; Vivek-Ananth RP; Samal A
    Sci Total Environ; 2019 Nov; 692():281-296. PubMed ID: 31349169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocrine-disrupting chemicals: an Endocrine Society scientific statement.
    Diamanti-Kandarakis E; Bourguignon JP; Giudice LC; Hauser R; Prins GS; Soto AM; Zoeller RT; Gore AC
    Endocr Rev; 2009 Jun; 30(4):293-342. PubMed ID: 19502515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocrine disrupting chemicals: human exposure and health risks.
    Yang M; Park MS; Lee HS
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2006; 24(2):183-224. PubMed ID: 17114110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exposure to endocrine disrupting compounds via the food chain: Is packaging a relevant source?
    Muncke J
    Sci Total Environ; 2009 Aug; 407(16):4549-59. PubMed ID: 19482336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocrine-disrupting chemicals (EDCs) and cancer: new perspectives on an old relationship.
    Modica R; Benevento E; Colao A
    J Endocrinol Invest; 2023 Apr; 46(4):667-677. PubMed ID: 36526827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methodological issues in human studies of endocrine disrupting chemicals.
    Lee DH; Jacobs DR
    Rev Endocr Metab Disord; 2015 Dec; 16(4):289-97. PubMed ID: 26880303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocrine disrupting chemicals: exposure, effects on human health, mechanism of action, models for testing and strategies for prevention.
    Yilmaz B; Terekeci H; Sandal S; Kelestimur F
    Rev Endocr Metab Disord; 2020 Mar; 21(1):127-147. PubMed ID: 31792807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of In Vitro Models for Studying the Mechanisms Underlying the Obesogenic Action of Endocrine-Disrupting Chemicals (EDCs) as Food Contaminants-A Review.
    Kowalczyk M; Piwowarski JP; Wardaszka A; Średnicka P; Wójcicki M; Juszczuk-Kubiak E
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocrine disrupting chemicals: effects on pituitary, thyroid and adrenal glands.
    Egalini F; Marinelli L; Rossi M; Motta G; Prencipe N; Rossetto Giaccherino R; Pagano L; Grottoli S; Giordano R
    Endocrine; 2022 Dec; 78(3):395-405. PubMed ID: 35604630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.